Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04245722 |
Title | FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Fate Therapeutics |
Indications | |
Therapies |
Cyclophosphamide + Fludarabine + FT596 + Obinutuzumab |
Age Groups: | adult | senior |
Covered Countries | USA |